Ozempic vs Saxenda for Weight Loss in Women: Which GLP-1 Works Better?

Sarah had been researching weight loss medications for three months when she finally brought a list of questions to her doctor's office. At the top: "Should I take Ozempic or Saxenda?" She'd read about both, knew they were GLP-1 medications, and understood they worked similarly—but the differences felt confusing. One required daily injections, the other weekly. One was newer to the weight loss conversation, the other FDA-approved specifically for obesity. She wasn't alone in her confusion. We see this question almost daily from women trying to make an informed choice about which medication aligns best with their lifestyle, health goals, and budget.

The truth is, while both medications belong to the same drug class and work through similar mechanisms, the practical differences between Ozempic (semaglutide) and Saxenda (liraglutide) matter quite a bit when you're the one administering injections and managing side effects. Women often respond to these medications differently than men due to hormonal influences, body composition differences, and metabolic variations throughout the menstrual cycle. Understanding these nuances helps you make a decision that's more likely to stick.

How These Medications Actually Work

Both Ozempic and Saxenda are GLP-1 receptor agonists, meaning they mimic a hormone your gut naturally produces after eating. This hormone does several things simultaneously: it signals your brain that you're full, slows down how quickly food leaves your stomach, and influences insulin secretion. The result? You feel satisfied with less food, experience fewer cravings, and your body handles blood sugar more efficiently.

But here's where they diverge. Saxenda contains liraglutide, which has been FDA-approved specifically for chronic weight management since 2014. It was actually the first GLP-1 medication to receive this approval. You inject it daily, starting at 0.6 mg and gradually increasing over five weeks to a maintenance dose of 3.0 mg. This daily routine gives you consistent medication levels in your bloodstream, but it also means remembering an injection every single day.

Ozempic, on the other hand, contains semaglutide—a longer-acting molecule that only requires weekly injections. While it's technically FDA-approved for type 2 diabetes rather than weight loss, doctors frequently prescribe it off-label for obesity management because the weight loss results have been so pronounced. The STEP 1 trial showed that patients on 2.4 mg semaglutide (the higher dose marketed as Wegovy) lost an average of 14.9% of their body weight over 68 weeks. That's substantially more than what we typically see with liraglutide.

The molecular structure makes the difference. Semaglutide has modifications that allow it to stick around in your system longer—its half-life is about seven days compared to liraglutide's 13 hours. This isn't just about convenience. The longer action means more sustained appetite suppression throughout the week, which many women find makes it easier to maintain consistent eating patterns without the peaks and valleys that can occur with shorter-acting medications.

In our clinical experience, women often prioritize the weekly dosing schedule of Ozempic because it integrates more seamlessly into busy lives. There's something psychologically easier about one injection per week versus seven. That said, some women actually prefer the daily ritual of Saxenda because it feels like a daily recommitment to their health goals. There's no universally "better" approach—it depends entirely on your personality and what you'll actually stick with long-term.

Weight Loss Results: What the Numbers Actually Show

Let's get specific about what you can realistically expect. Clinical trials give us the clearest picture, though individual results always vary based on diet, exercise, genetics, and adherence.

The SCALE Obesity and Prediabetes trial examined Saxenda in over 3,700 adults without diabetes. After 56 weeks, participants taking 3.0 mg liraglutide daily lost an average of 8% of their body weight, compared to 2.6% in the placebo group. About 63% of people on Saxenda lost at least 5% of their body weight, and 33% lost at least 10%. These are solid results, especially considering that losing just 5-10% of body weight can significantly improve metabolic health markers like blood pressure, cholesterol, and blood sugar.

Now compare that to semaglutide. The STEP 1 trial enrolled 1,961 adults with obesity or overweight. Those receiving 2.4 mg semaglutide weekly lost an average of 14.9% of their body weight after 68 weeks, versus 2.4% with placebo. An impressive 86% lost at least 5% of their body weight, and 50% lost at least 15%. That's nearly double the average weight loss seen with liraglutide.

For a 200-pound woman, these percentages translate to real numbers. With Saxenda, she might expect to lose around 16 pounds on average. With Ozempic at the higher dose, that number jumps to about 30 pounds. Of course, these are averages—some women lose significantly more, others less.

What we notice in practice is that the weight loss curve differs between the two medications. Saxenda users often see more gradual, steady weight loss throughout treatment. Semaglutide users frequently experience more dramatic early weight loss in the first few months, which can be motivating but also means you need to be more vigilant about adequate nutrition and protein intake to preserve muscle mass.

Women with PCOS or insulin resistance often respond particularly well to both medications since they address the underlying metabolic dysfunction. However, the greater weight loss typically seen with semaglutide can be especially beneficial for women dealing with PCOS, where weight loss of 10% or more often restores ovulation and improves other hormonal imbalances.

Cost factors into real-world effectiveness too. If a medication is prohibitively expensive and you can't maintain it long-term, even superior trial results become irrelevant. We'll address this more below, but it's worth noting that sustainability matters as much as peak effectiveness.

Side Effects and How Women Experience Them

Both medications come with similar side effect profiles since they work through the same mechanism. Nausea tops the list. About 44% of people taking Saxenda report nausea, especially during the dose escalation phase. With semaglutide, nausea affects approximately 44% of users as well in clinical trials.

Here's what that actually feels like for most women: a mild queasiness that's most noticeable in the first few hours after injection and typically worse during the first few weeks of treatment. It's usually not the dramatic, run-to-the-bathroom nausea—more like early pregnancy nausea or mild car sickness. For most people, it improves significantly after the first month as your body adjusts.

Other common GI side effects include diarrhea, constipation, vomiting, and abdominal discomfort. These occur in 20-30% of users with both medications. Constipation can be particularly troublesome for women, who already experience it more frequently than men due to hormonal influences on gut motility. Staying well-hydrated, eating adequate fiber, and sometimes using a gentle stool softener can help manage this.

One difference worth mentioning: because Saxenda requires daily injections and Ozempic only weekly, you're creating injection sites seven times as often with Saxenda. This increases the chances of injection site reactions—redness, itching, or small lumps under the skin. Most women rotate between abdomen, thighs, and upper arms to minimize this issue. With Ozempic's weekly schedule, injection site problems are less common simply because you're doing it less frequently.

Some women report feeling more fatigued or low-energy when starting these medications, likely related to eating substantially less than before. Your body is adjusting to fewer calories while the medication is ramping up. This usually improves within a month, but it's something to anticipate, especially if you have a demanding schedule or exercise regularly.

Gallbladder issues deserve mention. Rapid weight loss from any cause increases the risk of gallstones, and GLP-1 medications can compound this slightly. The risk is still relatively low—around 2-3% in clinical trials—but it's higher than placebo. Women already have a higher baseline risk of gallbladder problems than men, particularly if you've been pregnant, are over 40, or have a family history.

Hair thinning is something we occasionally see with rapid weight loss from GLP-1 medications, though it's not listed as a common side effect in the prescribing information. This is typically telogen effluvium—a temporary shedding that occurs 2-4 months after significant weight loss or metabolic stress. It's reversible, but it can be distressing. Ensuring adequate protein intake (at least 80-100 grams daily for most women) and taking a quality multivitamin can help minimize this.

In our clinical experience, women who titrate slowly, stay well-hydrated, eat protein-forward meals, and avoid high-fat foods during the adjustment period tend to have the mildest side effects with both medications.

Dosing, Administration, and Practical Considerations

The practical differences in how you take these medications affect daily life more than you might initially think.

Saxenda comes in a multi-dose pen that you inject subcutaneously (under the skin) once daily at any time of day. You start at 0.6 mg and increase by 0.6 mg each week until you reach the full 3.0 mg dose at week five. Each pen contains enough medication for about 6 days at the full dose, so you'll go through roughly five pens per month. The daily injection needs to become part of your routine—many women do it first thing in the morning or right before bed to establish consistency.

Ozempic requires just one injection per week, on the same day each week. You start at 0.25 mg for the first four weeks, increase to 0.5 mg for at least four weeks, then potentially move to 1 mg or even 2 mg depending on your response and tolerability. One pen contains four weekly doses. You can inject it any time of day, with or without food, which gives you flexibility. Forgot Monday morning? You can do it Monday evening or even Tuesday without significantly impacting effectiveness.

Injection technique is straightforward with both. You'll inject into fatty tissue on your abdomen (at least two inches from your belly button), thighs, or upper arms. The needles are tiny—much smaller than what most people imagine. Many women report that the anticipation is worse than the actual injection, which typically feels like a brief pinch or sometimes nothing at all.

Storage requirements differ slightly. Both need refrigeration before first use. Once you've started using a pen, Saxenda can stay at room temperature (below 86°F) for 30 days. Ozempic can remain at room temperature for 56 days after first use. If you travel frequently, Ozempic's longer room-temperature stability and weekly dosing make it more convenient.

The time investment differs too. With Saxenda, you're spending a few minutes every single day preparing and administering your injection. That's about 30-35 minutes per week. With Ozempic, it's just one 5-minute session weekly. For women juggling careers, families, and multiple responsibilities, this efficiency can be meaningful.

Cost is perhaps the most significant practical consideration. Brand-name Saxenda typically runs $1,400-$1,600 per month without insurance. Brand-name Ozempic costs about $900-$1,000 monthly. Insurance coverage varies wildly—some plans cover one but not the other, some require extensive prior authorization, and many exclude weight loss medications entirely even when prescribed off-label. Compounded versions of semaglutide have become increasingly available and affordable (like what we offer at Ozari Health), but compounded liraglutide is less common in the market currently.

What Women Should Know

Several factors specific to women's health deserve consideration when choosing between these medications. Hormonal fluctuations throughout the menstrual cycle can influence both appetite and side effects. Some women notice that nausea is worse during certain phases of their cycle, particularly the luteal phase (the two weeks before menstruation) when progesterone is elevated and already slows gastric emptying.

If you're planning pregnancy, both medications need to be discontinued. Animal studies have shown potential risks, so both Saxenda and Ozempic carry warnings about use during pregnancy. You should stop either medication at least two months before trying to conceive, which means you'll need a transition plan for maintaining weight loss through other means. For women with PCOS who weren't previously ovulating, these medications can restore fertility—which is wonderful if you're trying to conceive but means you need reliable contraception if you're not.

Women in perimenopause or menopause often find that GLP-1 medications help counteract the metabolic slowing and weight gain that commonly occur during this transition. The appetite suppression can be particularly helpful since many women experience increased cravings and decreased satiety during hormonal shifts. That said, bone health becomes increasingly important after menopause, so ensuring adequate protein and calcium intake while on these medications is essential.

Body composition matters too. Women naturally carry higher body fat percentages than men and tend to lose weight differently. While men often lose visceral fat around organs more readily, women may lose more subcutaneous fat initially. Both medications will reduce overall fat, but maintaining muscle becomes crucial. Resistance training and adequate protein (we usually recommend 0.7-1 gram per pound of goal body weight) help preserve lean mass during weight loss.

What Men Should Know

While this article focuses on women, men considering these medications should be aware of some male-specific factors. Men typically experience greater absolute weight loss on GLP-1 medications partly because they often start at higher body weights. The percentage weight loss is similar between genders, but a 15% loss means more pounds for someone who starts at 280 pounds versus 180 pounds.

Men report nausea and GI side effects at similar rates to women, though there's some evidence that men may have slightly less nausea overall. The mechanism isn't entirely clear but may relate to differences in gastric emptying rates between sexes.

Testosterone levels can improve with weight loss, particularly in men with obesity who have lower baseline testosterone. We've seen men regain energy, libido, and better body composition as they lose weight on these medications, likely related to reduced aromatization of testosterone to estrogen in fatty tissue.

Men should also be aware that rapid weight loss can occasionally trigger gout attacks if you're prone to them. Staying well-hydrated and discussing preventive medication with your doctor can help if you have a history of gout.

From the Ozari Care Team

We recommend thinking beyond just the clinical trial data when choosing between these medications. Consider your personality and lifestyle honestly. Are you someone who thrives on daily rituals and check-ins, or would the daily injection feel burdensome? Do you travel frequently for work, making weekly dosing more practical? Also, look at your budget realistically for long-term use—these medications work best when continued, so a medication you can afford consistently often delivers better real-world results than a "superior" option you can only take for a few months. Finally, whichever you choose, commit to protein-forward eating and regular movement to maximize muscle preservation and metabolic benefits.

Key Takeaways

• Ozempic (semaglutide) typically produces greater average weight loss—about 14.9% of body weight—compared to Saxenda's 8%, based on clinical trial data, though both are effective for metabolic health improvements.
• Saxenda requires daily injections while Ozempic needs only weekly administration, making the latter more convenient for most people but potentially less suitable for those who prefer daily health rituals.
• Side effect profiles are similar between both medications, with nausea, GI disturbances, and injection site reactions being most common, typically improving after the first month of treatment.
• Cost and insurance coverage vary significantly—brand-name Saxenda runs $1,400-$1,600 monthly versus $900-$1,000 for Ozempic, though compounded semaglutide offers more affordable access at around $99-$299 per month.
• Both medications should be discontinued at least two months before attempting pregnancy and may restore fertility in women with PCOS, requiring reliable contraception if pregnancy isn't desired.

Frequently Asked Questions

Can I switch from Saxenda to Ozempic or vice versa?

Yes, you can switch between these medications under medical supervision. Most doctors recommend stopping one medication and starting the other at its initial low dose rather than trying to calculate equivalent doses, since they're metabolized differently. The transition is typically smooth since both work through the same GLP-1 mechanism, so your body is already accustomed to that type of medication. You might experience some appetite increase during the few days between stopping one and the new one reaching effective levels, but this is temporary. Many women switch from Saxenda to semaglutide specifically because they prefer weekly dosing or want potentially greater weight loss results.

Will I regain weight if I stop taking these medications?

Weight regain is possible when stopping any weight loss medication, including Saxenda and Ozempic. Clinical trials show that people regain about two-thirds of lost weight within a year of discontinuation if they don't maintain behavioral changes. However, this isn't inevitable—it depends entirely on the habits you've built during treatment. The medication creates a window where eating less feels natural and sustainable, giving you time to establish new patterns around food, movement, and stress management. Those who use this time intentionally to rebuild their relationship with food and establish consistent activity tend to maintain more of their weight loss after stopping. Think of these medications as tools that make the work easier, not magic solutions that work independently of your efforts.

Which medication is better if I have PCOS?

Both medications can be beneficial for PCOS since weight loss of 5-10% often improves insulin resistance, restores ovulation, and reduces androgen levels. Some evidence suggests that greater weight loss produces more dramatic improvements in PCOS symptoms, which might give semaglutide a slight edge given its superior weight loss results in trials. However, the best medication is genuinely the one you'll stick with long-term. If daily Saxenda injections feel more manageable for you, or if your insurance covers it better, that practical advantage matters more than marginal effectiveness differences. Both medications improve metabolic health markers that matter for PCOS. We've seen excellent results with both in our patients with PCOS, often with restoration of regular cycles and improved fertility.

Do these medications work if I don't have diabetes?

Absolutely. While Ozempic is FDA-approved specifically for type 2 diabetes, both medications work effectively for weight loss in people without diabetes. In fact, the STEP 1 trial specifically enrolled people without diabetes to examine semaglutide's effects on weight. Saxenda is actually FDA-approved for chronic weight management in people with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition, regardless of diabetes status. The mechanisms that produce weight loss—appetite suppression, delayed gastric emptying, and enhanced satiety—work the same whether you have diabetes or not. One consideration: if you don't have diabetes, your insurance may be less likely to cover these medications, making out-of-pocket cost or compounded versions more relevant to your decision.

Can I drink alcohol while taking Saxenda or Ozempic?

Moderate alcohol consumption isn't prohibited with either medication, but there are some important considerations. Both medications slow gastric emptying, which means alcohol may be absorbed differently and could affect you more strongly than you're accustomed to. Some people find they feel intoxicated more quickly or experience worse hangovers. Additionally, alcohol contains empty calories that can interfere with weight loss goals, and drinking may increase nausea if you're already experiencing GI side effects from the medication. If you do drink, start with less than you'd normally consume to see how your body responds, stay well-hydrated, and avoid drinking on an empty stomach. Many of our patients find their interest in alcohol naturally decreases on these medications anyway—the appetite suppression and increased mindfulness about what you're putting in your body often extends to alcoholic beverages as well.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, shipped to your door. Learn more at ozarihealth.com.